A decision-support platform designed to help teams identify, evaluate and connect with suitable CMOs and CDMOs.

Make Confident CMO / CDMO Decisions

Accelerate Partner Identification

MAI CDMO Network enables users to rapidly shortlist relevant CDMOs based on technical capabilities, regulatory compliance, therapeutic focus, development stage and production scale. What traditionally takes months can be reduced to a structured, traceable process. Users can engage directly with the appropriate commercial or technical contacts, avoiding generic inboxes and ensuring that discussions start with the right technical and regulatory context.

High-Quality, Manufacturer-Provided Information

Accurate and current information is essential for informed manufacturing decisions. On MAI CDMO Network, CMO and CDMO profiles are created and maintained by the manufacturers themselves, ensuring that capabilities, capacities and certifications reflect operational reality. All profiles are reviewed by the MAI CDMO Network team to ensure clarity, relevance and consistency, providing a reliable foundation for partner evaluation.

A Practical Decision-Support Platform for Manufacturing Teams

MAI CDMO Network brings together structured manufacturer data, advanced filtering and guided selection workflows to support informed decision-making. The platform is designed to integrate naturally into the workflows of CMC, External Manufacturing and Procurement teams. Whether evaluating new manufacturing options, building supply chain resilience or preparing future development milestones, MAI CDMO Network provides a clear and reliable starting point.

The Strategic Responsibility of CDMO Selection

Selecting a Contract Manufacturing Organization (CMO) or Contract Development and Manufacturing Organization (CDMO) is a strategic responsibility for pharmaceutical and biopharmaceutical teams. Professionals in CMC, External Manufacturing, Operations and Procurement must align technical feasibility, regulatory requirements, development stage, scale, timelines and long-term reliability, often under significant time pressure and across multiple stakeholders.

Search CDMOs by Product Type

Biologics

Cell and gene therapies, recombinant proteins, monoclonal antibodies and vaccines.

Search Biologics CDMOs

Chemical-Synthetic

Small molecule APIs, intermediates and high-potency compounds.

Search Chemical CDMOs

FDF / Drug Products

Solid orals, injectables, topicals and complex formulations.

Search FDF CDMOs

Cosmetics

Contract manufacturing for skincare and personal care products.

Nutraceuticals

Vitamins, functional foods and dietary supplements.

Services Only

Analytics, packaging, logistics or quality-focused CDMOs.

Filter by Intended Use

Human use

Prescription, OTC and hospital-use pharmaceuticals.

Search by human use

Veterinary use

Companion animal and livestock products.

Search veterinary CDMOs

Match by Stage of Development

Investigational stage

Preclinical development, clinical trial material and tech transfer (Phase I�III).

Search clinical CDMOs

Commercial stage

Full-scale GMP manufacturing, validation and global supply (Phase IV and post-approval).

Search commercial CDMOs

Choose the Right Batch Size

Small batches

Early-stage trials, personalized medicine and niche indications.

Medium batches

Regional launches and scale-up programs.

Large batches

Global commercial supply and long-term manufacturing.

Join the World's Leading Pharmaceutical Collaboration Ecosystem

Access verified data from 15,000+ manufacturing plants and 1.2k+ active clinical trials. Make faster, safer, and more efficient outsourcing decisions.

+1.2k Active Trials

Target Specific Therapeutic Areas

Using ATC-based classification, MAI CDMO Network enables selection of CDMOs with experience in specific therapeutic areas, including oncology, cardiovascular, CNS, respiratory, dermatology, infectious diseases and more. Specialized capabilities such as radiopharmaceuticals, diagnostics and nutrition-related products can also be identified.

Consider Safety & Regulatory Complexity

Occupational Exposure Bands (OEB 1�5)

For potent and highly potent compounds.

Biological Safety Levels (BSL 1�4)

For biologics and advanced therapies.

Controlled Substances

Narcotics, DEA (Schedules I�V) and other authorizations.

Certifications That Matter

A Platform Built on Compliance

Each CDMO is tagged with applicable certifications and market approvals, including: ⬢ GMPs from EMA, FDA, Health Canada, PMDA, NMPA, ANVISA and other authorities. ⬢ International standards such as ISO, WHO GMP, NSF, BRCGS, ECOVADIS and Halal. ⬢ Regional approvals across more than 20 global markets. This allows rapid verification of regulatory suitability for target markets.

Discover Full-Service Capabilities

Development services

Preformulation, tech transfer and scale-up.

Manufacturing services

GMP production of drug substances and drug products.

Analytical services

QC/QA testing, method development and validation.

Packaging & logistics

Serialization, cold chain and international distribution.

Regulatory support

Dossier preparation, CMC guidance and audits.